Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression
收藏NIAID Data Ecosystem2026-03-14 收录
官方服务：
资源简介：
Single arm, prospective, exploratory clinical study of Disitamab Vedotin combined with Fruquintinib for advanced colorectal cancer with HER2 expression or mutation that has received at least two standard treatment failures
创建时间：
2023-01-15
